Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing and delivering innovative products to patients suffering from debilitating diseases such as lupus nephritis (LN).

How We’re Helping Patients

Latest News

May 17, 2017 • 12:00am EDT

Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis

Read Press Release View All News

May 15, 2017 • 12:00am EDT

Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights

Read Press Release View All News

May 9, 2017 • 12:00am EDT

Pharma Industry Veteran Dr. George Milne Joins Aurinia’s Board of Directors

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today